HomeAI · summaries
Storia in 6 fonti
Chai Discovery raises $400M for AI drug discovery as big pharma bets on machine learning over blockchain
Chai Discovery is raising $400M at a $3.4B valuation for AI drug discovery, backed by Pfizer, Eli Lilly, and OpenAI, raising questions for crypto's DeSci
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
- ·
cryptobriefing.com
Chai Discovery raises $400M for AI drug discovery as big pharma bets on machine learning over blockchain
Chai Discovery is raising $400M at a $3.4B valuation for AI drug discovery, backed by Pfizer, Eli Lilly, and OpenAI, raising questions for crypto's DeSci
- ·
endpoints.news
Chai Discovery gets $400M, tripling valuation from seven months ago
One of the hottest startups in the AI-generated drug discovery landscape has corralled $400 million in a Series C that triples its paper value from its last round of financing.
- ·
siliconangle.com
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma - SiliconANGLE
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma - SiliconANGLE
- ·
techfundingnews.com
Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal — TFN
Chai Discovery raised $400 million at a $3.8 billion valuation, tripling its worth in seven months and pushing total funding above $600 million across three rounds in eleven…
- ·
thenextweb.com
Chai Discovery raises $400M as AI drug discovery booms
Chai Discovery's $400M Series C triples its value to $3.8bn, a fresh sign that AI drug discovery has moved from promise to deployment at big pharma.